PRESS: Fierce Biotech - Forge Biologics

Six months after departing Abeona, Tim Miller, Ph.D., is on his next chapter: Forge Biologics, a gene therapy biotech that’s []Read More from PRESS: Fierce Biotech

Fierce Biotech's 2022 Fierce 15

Forge Biologics Manufacturing Gene Therapies for Life

10.03.23 FDA flags 'systemic bias' in Amgen Lumakras trial; Radiopharma deal buzz as Lilly drops $1.4B on Point, Novartis' Dx interest decays - Questex

Columbus Inno - Gene therapy startup Forge Biologics raises $90M on biotech manufacturing strength

Forge Biologics on LinkedIn: News! Forge Biologics and Ray Therapeutics, Inc. expand their AAV…

Columbus Inno - Forge Biologics expands, releases 'amazing' results in infants treated with its gene therapy

Columbus Inno - Gene therapy startup Forge Biologics raises $90M on biotech manufacturing strength

Forge Biologics Manufacturing Gene Therapies for Life

Articles by Zoey Becker's Profile, FiercePharma Journalist

Forge Bio's Combo Model for Gene Therapies Attracts $40M in Funding - Forge Biologics

Gene therapy engine' Forge debuts with $40M and Tim Miller at the helm

Fierce Pharma PR & Communications Summit

Forge blazes into California collaboration on production of AAV therapies

Endpoints News — J&J ends adult RSV vaccine development; The Broad's Feng Zhang outlines bacterial delivery in new paper

Pharma PR & Communications Summit